Gastroenterology and Liver

Gastrointestinal Oncology

Gastrointestinal oncology represents a rapidly evolving field with ongoing advancements in early detection, molecular profiling, and targeted therapies. This session will cover the latest developments in colorectal, gastric, esophageal, pancreatic, and hepatobiliary cancers, focusing on precision medicine and individualized treatment strategies. Researchers will present findings on biomarkers, genetic mutations, tumor microenvironment interactions, and immunotherapy applications that are shaping current and future cancer management. The track will also explore screening programs, risk stratification, and minimally invasive interventions that improve early detection rates and clinical outcomes, emphasizing evidence-based approaches.

Additionally, this session will highlight multidisciplinary collaboration in managing GI cancers, including integration of surgery, chemotherapy, radiotherapy, and emerging immunotherapeutic agents. Case studies, clinical trials, and translational research will be presented to provide a comprehensive understanding of disease mechanisms and treatment responses. Participants will also examine patient-centered approaches, survivorship care, and strategies to manage adverse effects and improve quality of life. Overall, this track aims to advance knowledge, encourage research submissions, and foster collaboration among oncologists, gastroenterologists, surgeons, and allied healthcare professionals engaged in gastrointestinal cancer care.